Variant report
Variant | nsv508198 |
---|---|
Chromosome Location | chr2:209935777-209950086 |
allele | n/a |
Outlinks | Ensembl   UCSC |
- TF binding region (count:22)
- CpG islands (count:0)
- Chromatin interactive region (count:0)
- LncRNA region (count:0)
- Mature miRNA region (count: 0)
- miRNA target sites (count:0)
(count:22 , 50 per page) page:
1
No. | Transcrition factor | Chromosome Location | Cell Line | Cell type | Cell Stage | Matched TF binding sites |
---|---|---|---|---|---|---|
1 | CTCF | chr2:209947512-209947571 | GM20000 | blood: | n/a | n/a |
2 | CTCF | chr2:209948063-209948098 | GM20000 | blood: | n/a | n/a |
3 | CUX1 | chr2:209949277-209949285 | GM12878 | blood: | n/a | n/a |
4 | FOS | chr2:209937121-209937185 | MCF10A-Er-Src | breast: | n/a | n/a |
5 | FOS | chr2:209938977-209939102 | MCF10A-Er-Src | breast: | n/a | n/a |
6 | FOS | chr2:209938923-209939225 | MCF10A-Er-Src | breast: | n/a | n/a |
7 | FOXA2 | chr2:209947965-209948384 | A549 | lung: | n/a | n/a |
8 | JUN | chr2:209941794-209942091 | HepG2 | liver: | n/a | chr2:209941939-209941952 |
9 | JUN | chr2:209941082-209941103 | H1-hESC | embryonic stem cell: | n/a | n/a |
10 | JUN | chr2:209949952-209950123 | H1-hESC | embryonic stem cell: | n/a | n/a |
11 | JUND | chr2:209941789-209942124 | HepG2 | liver: | n/a | n/a |
12 | JUND | chr2:209941010-209941155 | H1-hESC | embryonic stem cell: | n/a | n/a |
13 | JUND | chr2:209941858-209942047 | H1-hESC | embryonic stem cell: | n/a | n/a |
14 | MAFK | chr2:209938821-209938962 | HepG2 | liver: | n/a | chr2:209938910-209938921 chr2:209938909-209938920 chr2:209938910-209938921 |
15 | POLR2A | chr2:209950051-209950251 | MCF10A-Er-Src | breast: | n/a | n/a |
16 | POLR2A | chr2:209942689-209942911 | H1-hESC | embryonic stem cell: | n/a | n/a |
17 | POLR2A | chr2:209949763-209949767 | MCF10A-Er-Src | breast: | n/a | n/a |
18 | POLR2A | chr2:209948923-209949115 | H1-hESC | embryonic stem cell: | n/a | n/a |
19 | POLR2A | chr2:209939879-209940138 | MCF10A-Er-Src | breast: | n/a | n/a |
20 | POLR2A | chr2:209936342-209936504 | MCF10A-Er-Src | breast: | n/a | n/a |
21 | STAT3 | chr2:209939493-209939693 | MCF10A-Er-Src | breast: | n/a | n/a |
22 | ZNF143 | chr2:209941087-209941097 | H1-hESC | embryonic stem cell: | n/a | n/a |
No data |
No data |
No data |
No data |
No data |
Variant related genes | Relation type |
---|---|
HSPA8P6 | TF binding region |
No. | Variant name | Chromosome position | Chromatin state | Related regulatory elements | Target genes | Extended variants | Associated traits |
---|---|---|---|---|---|---|---|
1 | rs77361834 | chr2:209938903-209938904 | Inactive region | TF binding region | 1 gene(s) | Overlapped CNVs | n/a |
2 | rs184963442 | chr2:209938921-209938922 | Inactive region | TF binding region | 1 gene(s) | Overlapped CNVs | n/a |
3 | rs13420592 | chr2:209939027-209939028 | Inactive region | TF binding region | 1 gene(s) | Overlapped CNVs | n/a |
4 | rs139629625 | chr2:209939104-209939105 | Inactive region | TF binding region | 1 gene(s) | Overlapped CNVs | n/a |
5 | rs550701096 | chr2:209939187-209939188 | Inactive region | TF binding region | 1 gene(s) | Overlapped CNVs | n/a |
6 | rs545407277 | chr2:209939198-209939199 | Inactive region | TF binding region | 1 gene(s) | Overlapped CNVs | n/a |
7 | rs12694145 | chr2:209939205-209939206 | Inactive region | TF binding region | 1 gene(s) | LD-proxies of rSNPOverlapped rCNV | n/a |
8 | rs559411683 | chr2:209939505-209939506 | Inactive region | TF binding region | 1 gene(s) | Overlapped CNVs | n/a |
9 | rs79492710 | chr2:209939527-209939528 | Inactive region | TF binding region | 1 gene(s) | Overlapped CNVs | n/a |
10 | rs545412109 | chr2:209939544-209939545 | Inactive region | TF binding region | 1 gene(s) | Overlapped CNVs | n/a |
11 | rs148764092 | chr2:209939546-209939547 | Inactive region | TF binding region | 1 gene(s) | Overlapped CNVs | n/a |
12 | rs531055422 | chr2:209939580-209939581 | Inactive region | TF binding region | 1 gene(s) | Overlapped CNVs | n/a |
13 | rs569317807 | chr2:209939585-209939586 | Inactive region | TF binding region | 1 gene(s) | Overlapped CNVs | n/a |
14 | rs546372220 | chr2:209939610-209939611 | Inactive region | TF binding region | 1 gene(s) | Overlapped CNVs | n/a |
15 | rs569152352 | chr2:209939656-209939657 | Inactive region | TF binding region | 1 gene(s) | Overlapped CNVs | n/a |
16 | rs537394744 | chr2:209939660-209939661 | Inactive region | TF binding region | 1 gene(s) | Overlapped CNVs | n/a |
17 | rs186331611 | chr2:209939896-209939897 | Inactive region | TF binding region | 1 gene(s) | Overlapped CNVs | n/a |
18 | rs529217740 | chr2:209939922-209939923 | Inactive region | TF binding region | 1 gene(s) | Overlapped CNVs | n/a |
19 | rs190010539 | chr2:209939975-209939976 | Inactive region | TF binding region | 1 gene(s) | Overlapped CNVs | n/a |
20 | rs113035802 | chr2:209940048-209940049 | Inactive region | TF binding region | 1 gene(s) | Overlapped CNVs | n/a |
21 | rs557204041 | chr2:209940103-209940104 | Inactive region | TF binding region | 1 gene(s) | Overlapped CNVs | n/a |
22 | rs369004723 | chr2:209941055-209941056 | Inactive region | TF binding region | 1 gene(s) | Overlapped CNVs | n/a |
23 | rs150838463 | chr2:209941080-209941081 | Inactive region | TF binding region | 1 gene(s) | Overlapped CNVs | n/a |
24 | rs370562151 | chr2:209941155-209941156 | Inactive region | TF binding region | 1 gene(s) | Overlapped CNVs | n/a |
25 | rs559313839 | chr2:209941636-209941637 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
26 | rs547054804 | chr2:209941678-209941679 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
27 | rs138187793 | chr2:209941699-209941700 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
28 | rs533189562 | chr2:209941724-209941725 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
29 | rs572076840 | chr2:209941725-209941726 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
30 | rs191559312 | chr2:209941730-209941731 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
31 | rs114803484 | chr2:209941832-209941833 | Enhancers | TF binding region | 1 gene(s) | Overlapped CNVs | n/a |
32 | rs116930191 | chr2:209941844-209941845 | Enhancers | TF binding region | 1 gene(s) | Overlapped CNVs | n/a |
33 | rs577406008 | chr2:209941856-209941857 | Enhancers | TF binding region | 1 gene(s) | Overlapped CNVs | n/a |
34 | rs17675648 | chr2:209941861-209941862 | Enhancers | TF binding region | 1 gene(s) | Overlapped CNVs | n/a |
35 | rs556746830 | chr2:209941868-209941869 | Enhancers | TF binding region | 1 gene(s) | Overlapped CNVs | n/a |
36 | rs534703980 | chr2:209941887-209941888 | Enhancers | TF binding region | 1 gene(s) | Overlapped CNVs | n/a |
37 | rs184827728 | chr2:209941893-209941894 | Enhancers | TF binding region | 1 gene(s) | Overlapped CNVs | n/a |
38 | rs116529680 | chr2:209941900-209941901 | Enhancers | TF binding region | 1 gene(s) | Overlapped CNVs | n/a |
39 | rs57209421 | chr2:209941918-209941919 | Enhancers | TF binding region | 1 gene(s) | Overlapped CNVs | n/a |
40 | rs540553214 | chr2:209941930-209941931 | Enhancers | TF binding region | 1 gene(s) | Overlapped CNVs | n/a |
41 | rs560179755 | chr2:209941947-209941948 | Enhancers | TF binding region | 1 gene(s) | Overlapped CNVs | n/a |
42 | rs554510613 | chr2:209941957-209941958 | Enhancers | TF binding region | 1 gene(s) | Overlapped CNVs | n/a |
43 | rs532385726 | chr2:209941974-209941975 | Enhancers | TF binding region | 1 gene(s) | Overlapped CNVs | n/a |
44 | rs189632226 | chr2:209942011-209942012 | Enhancers | TF binding region | 1 gene(s) | Overlapped CNVs | n/a |
45 | rs569956992 | chr2:209942012-209942013 | Enhancers | TF binding region | 1 gene(s) | Overlapped CNVs | n/a |
46 | rs16842384 | chr2:209942078-209942079 | Enhancers | TF binding region | 1 gene(s) | LD-proxies of rSNPOverlapped rCNV | n/a |
47 | rs192882663 | chr2:209942083-209942084 | Enhancers | TF binding region | 1 gene(s) | Overlapped CNVs | n/a |
48 | rs568077929 | chr2:209942091-209942092 | Enhancers | TF binding region | 1 gene(s) | Overlapped CNVs | n/a |
49 | rs150636371 | chr2:209942103-209942104 | Enhancers | TF binding region | 1 gene(s) | Overlapped CNVs | n/a |
50 | rs138912297 | chr2:209942110-209942111 | Enhancers | TF binding region | 1 gene(s) | Overlapped CNVs | n/a |
Disease | PMID | Source |
---|---|---|
Ewing''s sarcoma | 21437220 | CNVD |
Glioblastoma multiforme | 21080181 | CNVD |
Medulloblastoma | 21979893 | CNVD |
Ependymoma | 16718352 | CNVD |
Melanoma | 18172304 | CNVD |
Cancer | 16751803 | CNVD |
T-cell prolymphocytic leukemia | 19278963 | CNVD |
Acute lymphoblastic leukemia | 20067559 | CNVD |
Acute lymphoblastic leukemia | 21980252 | CNVD |
Breast cancer | 17603634 | CNVD |
Testicular germ cell tumor | 18059402 | CNVD |
Breast cancer | 16272173 | CNVD |
Ewing''s sarcoma | 17952124 | CNVD |
Cancer | 21637783 | CNVD |
Non-syndromic sensorineural hearing loss | 18471307 | CNVD |
Esophageal squamous carcinoma | 21637470 | CNVD |
Liposarcoma | 21253554 | CNVD |
Endometrial cancer | 22040021 | CNVD |
Breast cancer | 21264507 | CNVD |
Embryonal rhabdomyosarcoma | 16790082 | CNVD |
Autism | 16446308 | CNVD |
Autism | 19401682 | CNVD |
Colorectal cancer | 16272173 | CNVD |
Lung cancer | 18438408 | CNVD |
Prostate cancer | 18632612 | CNVD |
Acute myeloid leukemia | 20729466 | CNVD |
small cell lung cancer | 20016488 | CNVD |
Biliary cancer | 20360734 | CNVD |
Breast cancer | 20360734 | CNVD |
Coronary artery disease | 20360734 | CNVD |
Crohn''s disease | 20360734 | CNVD |
Hypertension | 20360734 | CNVD |
Rheumatoid arthritis | 20360734 | CNVD |
Type 1 diabetes | 20360734 | CNVD |
Type 2 diabetes | 20360734 | CNVD |
Urothelial carcinoma | 21177765 | CNVD |
Hodgkin''s lymphoma | 17606441 | CNVD |
Cervical cancer | 21062161 | CNVD |
Adenoid cystic carcinoma | 18698036 | CNVD |
Non-muscle invasive bladder neoplasm | 19445696 | CNVD |
Non-small cell lung cancer | 21829676 | CNVD |
Autism | 20808228 | CNVD |
Renal cell carcinoma | 18765545 | CNVD |
Ovarian cancer | 19193619 | CNVD |
Non-small cell lung cancer | 18676828 | CNVD |
Oral squamous cell carcinoma | 17134496 | CNVD |
Myofibroblastic sarcoma | 19369631 | CNVD |
Chordoma | 18071362 | CNVD |
Myelofibrosis | 22110671 | CNVD |
Schizophrenia | 18923514 | CNVD |
Schizophrenia | 22241247 | CNVD |
Non-syndromic sensorineural hearing loss | 15273396 | CNVD |
Urothelial cell carcinoma | 18451213 | CNVD |
Acute lymphoblastic leukemia | 22237106 | CNVD |
Developmental delay | 21147756 | CNVD |
No. | Chromosome Location | Chromatin state | Cell line | Tissue |
---|---|---|---|---|
1 | chr2:209941600-209942600 | Enhancers | HUES48 Cell Line | embryonic stem cell |
2 | chr2:209941800-209942400 | Enhancers | iPS-20b Cell Line | embryonic stem cell |
3 | chr2:209942200-209942400 | Enhancers | iPS-18 Cell Line | embryonic stem cell |
4 | chr2:209943200-209943600 | Weak transcription | ES-I3 Cell Line | embryonic stem cell |
5 | chr2:209944800-209945000 | Enhancers | hESC Derived CD184+ Endoderm Cultured Cells | ES cell derived |
6 | chr2:209945200-209945400 | Enhancers | iPS-15b Cell Line | embryonic stem cell |
7 | chr2:209945400-209949000 | Weak transcription | ES-I3 Cell Line | embryonic stem cell |
8 | chr2:209945400-209949200 | Weak transcription | iPS-15b Cell Line | embryonic stem cell |
9 | chr2:209947800-209949200 | Weak transcription | HUES48 Cell Line | embryonic stem cell |
10 | chr2:209949000-209950000 | Enhancers | ES-I3 Cell Line | embryonic stem cell |
11 | chr2:209949200-209949600 | Enhancers | HUES64 Cell Line | embryonic stem cell |
12 | chr2:209949200-209950000 | Enhancers | HUES48 Cell Line | embryonic stem cell |
13 | chr2:209949200-209950200 | Enhancers | iPS-15b Cell Line | embryonic stem cell |
14 | chr2:209950000-209951400 | Weak transcription | ES-I3 Cell Line | embryonic stem cell |
15 | chr2:209950000-209955600 | Weak transcription | HUES48 Cell Line | embryonic stem cell |